Side-by-side comparison of AI visibility scores, market position, and capabilities
Monett MO community bank fintech (NASDAQ: JKHY) ~$2.3B revenue; SilverLake/Banno for 7,500+ community banks, Victor Technologies PaaS acquisition, 99%+ retention competing with Fiserv and FIS for community financial institution tech.
Jack Henry & Associates, Inc. is a Monett, Missouri-based financial technology company — publicly traded on NASDAQ (NASDAQ: JKHY) as an S&P 500 Financials component — providing core banking systems, digital banking platforms, payment processing, and financial technology infrastructure to approximately 7,500 community banks and credit unions across the United States through approximately 7,500 employees. Jack Henry's flagship products include SilverLake (core banking for large community banks), CIF 20/20 (community credit union core banking), Banno Digital Platform (mobile and online banking for community institution customers), and Jack Henry Payments (ACH, RTP, FedNow, and card payment processing). The company acquired Victor Technologies from MVB Financial Corp in 2025 — a cloud-native, API-first provider of direct-to-core embedded payments solutions that processes billions of dollars in payments monthly — expanding Jack Henry's Payments-as-a-Service (PaaS) capabilities for financial institutions serving fintech companies and commercial customers seeking API-based payment integration. CEO Greg Adelson leads Jack Henry's strategy of deepening community bank and credit union platform dependency by expanding from core banking into payments, digital banking, and open API banking (enabling community institutions to partner with fintechs through Jack Henry's Banno Open Banking platform rather than building their own API infrastructure). In fiscal year 2024 (ending June 2024), Jack Henry reported revenue of approximately $2.3 billion.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.